<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of Fisheries Sciences</title>
<title_fa>مجله علوم شیلاتی ایران</title_fa>
<short_title>IJFS</short_title>
<subject>Agriculture</subject>
<web_url>http://jifro.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>1562-2916</journal_id_issn>
<journal_id_issn_online>2322-5696</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.18869/acadpub.ijfs</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1395</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2017</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<volume>16</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>fa</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Immunological findings in shrimp Litopenaeus vannamei exposed to attenuated WSSV vaccine produced by Gamma irradiation</title>
	<subject_fa>fish disease</subject_fa>
	<subject>fish disease</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Orginal research papers</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;&lt;a name=&quot;OLE_LINK25&quot;&gt;&lt;/a&gt;&lt;a name=&quot;OLE_LINK3&quot;&gt;&lt;/a&gt;&lt;a name=&quot;OLE_LINK16&quot;&gt;&lt;/a&gt;&lt;a name=&quot;OLE_LINK13&quot;&gt;In this research, White spot syndrome virus (WSSV) with 10&lt;sup&gt;5.4&lt;/sup&gt;LD&lt;sub&gt;50&lt;/sub&gt;.mL&lt;sup&gt;-1&lt;/sup&gt; inactivated with gamma irradiation at a dose rate of 14-15 kGy.sec&lt;sup&gt;-1&lt;/sup&gt; was used as a vaccine. Three hundred and sixty shrimp of &lt;em&gt;Litopenaeus vannamei, &lt;/em&gt;medium body weight (MBW) 1.0&amp;plusmn;0.17g), were prepared and experimentally exposed. They were distributed among four groups, inclusing vaccinated-virus exposed (T1), vaccinated-nonvirus exposed (T2), virus exposed (Positive control as T3) and non-vaccinated-non-virus exposed (Negative control as T4). The mortality percent of T1 started from day 5 and reached the highest (50%) on day 11 and remained constant until end of the experiment. In T2, no mortality was observed until the 3&lt;sup&gt;rd &lt;/sup&gt;day and the maximum mortality (20%) was observed on day 9. On the other hand, no remarkable mortality was recorded for T4 unlike T3 in which the mortality started on day 2 and stopped on day 7. The minimum density of hyalinocyte was calculated in T4 but the maximum one was found in T3 (17.77&amp;plusmn;0.33) with no significant differences (&lt;em&gt;p&lt;/em&gt;&lt;0.05) compared to T2 (16.59&amp;plusmn;0.96). A significant difference (&lt;em&gt;p&lt;/em&gt;&lt;0.05) was observed between the values of Total Haemocyte Count (THC) before and after exposing to virus in T1. Total Protein Plasma (TPP) decreased to 29.03&amp;plusmn;3.41, while it was higher than 25.96&amp;plusmn;2.75 in T3 after 7 days. Such results might be responsible for developing resistance against WSSV in gamma irradiant vaccine in &lt;em&gt;L. vannamei&lt;/em&gt; in comparison to T3 while the cause of mortality in T2 could be due to the lower effectiveness.&lt;/a&gt;&lt;/p&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>WSSV, Gamma irradiant, Haemolymph parameters, Mortality rate</keyword>
	<start_page>382</start_page>
	<end_page>396</end_page>
	<web_url>http://jifro.ir/browse.php?a_code=A-10-23-10&amp;slc_lang=fa&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>D.</first_name>
	<middle_name></middle_name>
	<last_name>Boreyri</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>damonboreyri@yahoo.com</email>
	<code>100319475328460038083</code>
	<orcid>100319475328460038083</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>M.</first_name>
	<middle_name></middle_name>
	<last_name>Afsharnasab</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460038084</code>
	<orcid>100319475328460038084</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>A.A.</first_name>
	<middle_name></middle_name>
	<last_name>Motalebi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460038085</code>
	<orcid>100319475328460038085</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>A.</first_name>
	<middle_name></middle_name>
	<last_name>Haghigh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460038086</code>
	<orcid>100319475328460038086</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
